A

Aquestive Therapeutics
D

AQST

3.72000
USD
0.05
(1.22%)
مغلق
حجم التداول
20,517
الربح لكل سهم
-1
العائد الربحي
-
P/E
-6
حجم السوق
369,499,892
أصول ذات صلة
A
ACRE
0.01400
(0.28%)
4.93500 USD
A
ADMA
0.120
(0.66%)
18.260 USD
ALNY
ALNY
-4.39
(-1.33%)
325.26 USD
A
ANIP
0.100
(0.15%)
65.270 USD
A
ARWR
-0.120
(-0.71%)
16.790 USD
A
AXSM
1.415
(1.36%)
105.335 USD
B
BCRX
-0.10000
(-1.11%)
8.94000 USD
B
BHC
-0.14000
(-1.97%)
6.98000 USD
C
CRBP
-0.15750
(-2.03%)
7.60000 USD
المزيد
الأخبار المقالات

العنوان: Aquestive Therapeutics

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.